Solitary plasmacytoma in remission is a localized form of plasma cell neoplasm characterized by the presence of a single tumor of monoclonal plasma cells. It is clinically significant as it indicates a stage of disease where the tumor is no longer active, allowing for appropriate management and monitoring. The ICD-10 Code C90.31 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.
ICD-10 Code C90.31 represents solitary plasmacytoma in remission, a condition where a single plasma cell tumor has responded to treatment and is no longer active. This code is used in clinical documentation and billing to indicate that the patient has achieved remission, which is crucial for treatment planning, follow-up care, and ensuring appropriate reimbursement for healthcare services.
Solitary plasmacytoma in remission occurs when a localized plasma cell tumor has been treated successfully, resulting in the absence of active disease. This condition requires ongoing monitoring to prevent progression to multiple myeloma. Medical attention is necessary to manage potential complications and ensure continued remission.
ICD-10 Code C90.31 is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a critical role in both acute and chronic care settings, ensuring that healthcare providers have a clear understanding of the patient's condition and treatment history.
In SOAP notes, ICD-10 Code C90.31 connects subjective patient reports and objective clinical findings to a formal diagnosis of solitary plasmacytoma in remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of solitary plasmacytoma in remission focuses on monitoring and supportive care to maintain remission status. Treatment may include disease-specific approaches to prevent recurrence.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C90.31 is crucial for billing purposes, particularly in hospital, ER, or oncology settings, as it indicates the patient's remission status.
| CPT Code | Description |
|---|---|
| 99213 | Established patient office visit, moderate complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C90.31 for Solitary plasmacytoma in remission
What does it mean if a patient has solitary plasmacytoma in remission?
It indicates that the patient had a localized plasma cell tumor that has responded to treatment and is currently inactive, requiring ongoing monitoring to prevent recurrence.
How is solitary plasmacytoma in remission monitored?
Monitoring typically involves regular follow-up appointments, imaging studies, and laboratory tests to assess for any signs of recurrence or progression.
Can solitary plasmacytoma in remission progress to multiple myeloma?
Yes, solitary plasmacytoma can progress to multiple myeloma if not monitored closely, which is why regular follow-up is essential.
What are the treatment options for solitary plasmacytoma in remission?
Treatment primarily focuses on monitoring and supportive care, including pain management and physical therapy, as the condition is not infectious.
Clinical Notes
SOAP notes
DAP notes
AI medical notes